Coherent Corp. (COHR)
Live price chart, market sentiment, and community perspectives for Coherent Corp. (NYSE: COHR).
Live price chart, market sentiment, and community perspectives for Coherent Corp. (NYSE: COHR).
Looking at the options desk and post-earnings tape action, the real issue for COHR isn't demand—it's that the bar was simply set too high after an 189% rally over the past year. When a company posts a clean earnings beat with Q4 revenue hitting $2.05 billion and still sees after-hours selling, it signals aggressive profit-taking and crowded positioning ahead of the print. We need to watch how quickly institutional buyers step back in near the $330 level before committing fresh capital.
From a quantitative risk management perspective, COHR's valuation multiples—sitting above 40 times EBITDA and over 60 times adjusted earnings based on fiscal 2026 results—are quite demanding. However, if management hits their consensus projections of $9.46 per share and $2.8 billion in EBITDA for the full year, forward EV/EBITDA compresses rapidly toward 25x. The core risk lies in whether the explosive datacom demand can maintain this velocity through 2028 without hitting supply or macro bottlenecks.
As a bio-analyst transitioning into optical components supporting high-performance computing, the fundamental shift in Coherent's revenue mix caught my eye. Seeing their datacenter and communications mix jump to 75% from 41% a year ago, paired with expanded 6-inch indium phosphide capacity, shows that management's capital allocation is directly fueling higher-volume production. Order visibility extending into calendar 2028 provides a rare multi-year runway for technical validation.
Tracking the technicals on our desk, COHR's recent 9.78% bounce after its initial post-earnings slump highlights underlying resilience in the technology equipment sector. Nevertheless, we are tracking persistent headwinds, including industrial segment weakness and customer concentration risks. Until gross margin compression concerns are fully alleviated by scaling production, volatility will likely remain elevated around key psychological price thresholds.
In our market intelligence group, the debate centers on whether COHR's outperformance can survive a normalization in AI infrastructure spending. While management guided Q1 fiscal 2027 revenue up to $2.4 billion with non-GAAP EPS up to $2.05, the market is pricing in near-perfection. Breakthrough wins in co-packaged optics and optical circuit switches will be necessary to justify these rich multiples over a multi-year horizon.
Explore plasma cleansing, somatic organ swaps, and BCI.